"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

Illumina Inc (NASDAQ:ILMN ... This analysis is based on information available up to February 17, 2025. Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and ...

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ: ILMN ), a US-based company. This move ...

2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and array-based technologies, today announced a collaboration with Broad Clinical Labs to rapidly ...

While Illumina is still assessing the consequences of being added to China’s unreliable entity list earlier this month, Chinese makers of instruments that read genetic information have wasted little ...

The ban aims to protect the country’s “national sovereignty and security," and it follows US tariffs against Beijing, ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Kent Lake PR LLC (“Kent Lake”), a holder of 6.9% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

China announced it would impose additional tariffs on certain US agricultural imports from March 10, 2025, in retaliation ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...